ABBV - abbvie.com Total Company Value

Brandmark of AbbVie Corp. (ABBV)

The price action for AbbVie Inc. (ABBV) shown on this chart allows for a valuation of the business amid the struggle for market share and the risk of losing exclusive drug rights, with the metric standing at 569677.88. The holding company leverages its expertise in developing high-demand biomedical products that ensure high returns. Production capacities are constantly upgraded to expand drug output, supporting the overall efficiency of the enterprise.

ABBV (abbvie.com) Total Company Value history from 11/23/2025 to 10/29/2026

AbbVie Inc. (ABBV) - metric breakdowns and financial figures

- stock price and consensus target price:
Price Chart AbbVie Inc|ABBV - Analyst Consensus Forecast
- market capitalization statistics:
Market Value AbbVie|ABBV - Real Price to Acquire Entire Company
- business book valuation details:
Net Assets per Single Share AbbVie|ABBV - Company Book Value|Market Capitalization to Net Assets abbvie.com|ABBV - Company Total Assets
- company total debt and liquidity indicators:
All Debt to Shareholders' Equity Ratio AbbVie Inc.|ABBV - Long-Term Debt to Capital|Short-Term Debt to Capital abbvie.com|ABBV - Company Debts|Debt to Net Assets Ratio AbbVie|ABBV - Company Long-Term Debt|Company Current Liabilities AbbVie|Quick Ratio abbvie.com
- net income and valuation multiples indicators:
ABBV - Net Income
Analysis of all company metrics:AbbVie Inc
Brand item of AbbVie Inc.

Enterprise value represents the total acquisition price of a business, combining market capitalization and net debt minus liquid assets. The active M&A strategy of AbbVie Inc. (ABBV) to refresh its drug portfolio is reflected in the enterprise value, where increased borrowing for M&A transactions directly impacts the company's final capital valuation.

Competitors of AbbVie Inc. (ABBV)

Lilly - Total Company Value|AstraZeneca AB - Enterprise Value|NVS: Total Company Value|MRK (Merck & Co., Inc.) - Real Price to Acquire Entire Company|NVO (novonordisk.com) - Total Company Value|Total Company Value Amgen|Pfizer Inc - Full Business Value|Enterprise Value SNY|BMY (Bristol-Myers Squibb Co.) - Value Adjusted for Debt and Cash|Enterprise Value GSK (GlaxoSmithKline)|Enterprise Value takeda.com TAK|TEVA - Total Company Value|Value Adjusted for Debt and Cash RDY (Dr. Reddy's Laboratories Limited)|Viatris Corp (VTRS) - Total Company Value|Real Price to Acquire Entire Company Roivant Corp|ZLAB (Zai Lab Limited) - Enterprise Value|Enterprise Value bauschhealth.com|Real Price to Acquire Entire Company COSM (Cosmos Health)